跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
anti-Claudin-18.2 monoclonal antibody
首页
药物
anti-Claudin-18.2 monoclonal antibody
anti-Claudin-18.2 monoclonal antibody
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Anti-human claudin 18.2 monoclonal antibody and application thereof
US 12129296 B2
申请人: REYOUNG SUZHOU BIOLOGY SCIENCE & TECH CO LTD
优先权: 2018
CN
US
2 件公开
ANTIBODIES BINDING HUMAN CLAUDIN 18.2 AND USES THEREOF
EP 4219558 A1
申请人: BEIJING MABWORKS BIOTECH CO LTD
优先权: 2019
EP
US
2 件公开
CLAUDIN18.2 HUMANIZED ANTIBODY AND APPLICATION THEREOF
EP 4495140 A4
申请人: SUNSHINE LAKE PHARMA CO LTD
优先权: 2022
EP
PHARMACEUTICAL COMBINED PREPARATION CONTAINING CLAUDIN18.2 PG CAR-T PREPARATION AND PG ANTIBODY PREPARATION AND USE THEREOF
WO 2024240200 A1
申请人: INNOVENT CELLS PHARMACEUTICALS SU ZHOU CO LTD
优先权: 2023
WO
ANTI-HUMAN CLAUDIN 18.2 ANTIBODY AND USE THEREOF
WO 2025206223 A1
申请人: TSUKITA SACHIKO
优先权: 2024
WO
药物
反馈